Physician profile
Adam J Ball
NPI 1366438517
$10,450.61
in general payments reported to CMS, 2019-2025
52 companies · $1,389 in 2025
The $1,389 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,640 · 2020: $848 · 2021: $1,730 · 2022: $1,336 · 2023: $2,195 · 2024: $1,313 · 2025: $1,389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,538 · Education: $233 · Travel and Lodging: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,538.14 |
| Education | $232.99 |
| Travel and Lodging | $125.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,205.96 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $1,037.60 | 2019-2025 | Erleada |
| Antares Pharma, INC. | $888.60 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Myriad Genetic Laboratories, INC. | $808.19 | 2021-2025 | Prolaris, Myrisk |
| Endo Pharmaceuticals INC. | $807.65 | 2019-2024 | Xiaflex, Aveed, Edex |
| Coloplast Corp | $572.10 | 2019-2025 | Self-Cath, Titan, Speedicath |
| Allergan, INC. | $474.07 | 2019-2021 | |
| Endo USA, INC. | $332.55 | 2024-2025 | Xiaflex, Aveed |
| Pfizer INC. | $321.66 | 2019-2025 | |
| Biofire Diagnostics, LLC | $300.00 | 2019 | |
| Axonics, INC. | $296.56 | 2023-2024 | Axonics |
| Olympus America INC. | $276.07 | 2021-2024 | Itind System, Soltive |
| Bayer Healthcare Pharmaceuticals INC. | $224.99 | 2019-2025 | |
| Laborie Medical Technologies Corp. | $211.48 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System, Eclipse |
| C. R. Bard, INC. & Subsidiaries | $200.00 | 2021 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.